ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Insider Masaru Matsuda sold $32K of Arcutis Biotherapeutics, Inc.
Sold$32,124
$26.12Price
1,230Shares
−1%Stake
What ARQT did after the filing
- The stock from Thu, Aug 6 open, $29.21
- −11.1%
- S&P 500, same days
- +0.4%
Measured over 30 trading days, to the Sep 21 close.
Traded Mon, Aug 3. Filed Wed, Aug 5, 9:42 PM ET, after the close. Returns use the Aug 6 open and the Sep 21 close. Not investment advice.